NCT02877303 2026-05-20Blinatumomab, Inotuzumab Ozogamicin, and Combination Chemotherapy as Frontline Therapy in Treating Patients With B Acute Lymphoblastic LeukemiaM.D. Anderson Cancer CenterPhase 2 Recruiting80 enrolled